MPN Data Highlights from EHA 2025 June 15, 2025 Forward Looking Statements Except for the historical information set forth herein, the matters set forth in this release contain predictions, estimates and other forward-looking statements, including any discussion of the following: the potential presented by Incyte's portfolio, including the disease modifying potential and the potential path to a cure for patients with MPNs offered by INCA033989; planned next steps for INCA033989, including initiating a regis ...